Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Shares Slide 5.13 Percent After Bank Downgrades Stock

NEW YORK, July 6 (GenomeWeb News) - Shares in Molecular Devices were down 5.13 percent, or $1.13, at $20.67 in mid-afternoon trading after an investment bank downgraded the company's stock.

 

Thomas Weisel downgraded the shares to 'Peer Perform' from 'Outperform.'

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.